Raymond James & Associates »

Vaneck Vectors Pharmaceutical etf shares owned by Raymond James & Associates

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Raymond James & Associates from 13F filings

Historical chart of Raymond James & Associates investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Raymond James & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $555k 6.1k 90.70
2023-12-31 $404k 5.0k 81.37
2023-09-30 $390k 4.9k 79.86
2023-06-30 $322k 4.1k 78.77
2023-03-31 $521k 6.7k 77.63
2022-12-31 $2.3M 30k 77.74
2022-09-30 $901k 13k 67.24
2022-06-30 $1.0M 13k 76.87
2022-03-31 $912k 11k 79.78
2021-12-31 $792k 10k 76.99
2021-06-30 $264k 3.6k 73.15
2021-03-31 $250k 3.6k 69.04
2020-12-31 $245k 3.7k 66.45
2020-09-30 $267k 4.3k 62.28
2020-06-30 $267k 4.3k 62.28
2020-03-31 $229k 4.2k 54.41
2019-12-31 $232k 3.6k 64.28
2019-03-31 $310k 5.1k 60.78
2018-12-31 $279k 5.1k 54.71
2018-09-30 $5.7M 89k 64.35
2018-06-30 $5.4M 92k 59.00
2018-03-31 $5.2M 92k 56.83
2017-12-31 $5.4M 92k 59.31
2017-09-30 $5.1M 89k 57.76
2017-06-30 $5.8M 98k 59.06
2017-03-31 $5.4M 97k 55.14
2016-12-31 $5.0M 95k 52.51
2016-09-30 $5.3M 93k 57.46
2016-06-30 $5.2M 89k 58.62